Dominion Biotech

Dominion Biotech is a leading biotechnology research company dedicated to redefining the future of drug discovery. By providing next-generation, human-relevant research models and services, Dominion Biotech accelerates the development of safer, more effective therapies. Focusing on replacing outdated animal models with patient-derived systems that truly reflect human biology, Dominion Biotech is at the forefront of innovation.

Dominion Biotech specializes in creating and deploying patient-derived cell models, including organoids and autologous (patient-matched) blood services, to support precision medicine and translational research. Equipped with a comprehensive suite of technologies and tools, Dominion Biotech supports end-to-end drug screening and biological research. Capabilities include high-content screening, immuno-oncology assays, live-cell imaging, flow cytometry, automated drug dosing, confocal microscopy, and next-generation sequencing (NGS).

Located at Alderley Park, England SK10 4JS, GB, Dominion Biotech leverages a broad network of hospitals and biobanks to offer the unique ability to source and construct custom cohorts of patient-derived models. This enables partners to explore disease-specific biology and patient variability at an unprecedented level of precision.

Dominion Biotech invites you to explore a customized and exclusive company showcase and product listing on our platform.